Login / Signup

Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1.

Diletta FontanaFederica MalighettiMatteo VillaAlfonso ZambonCarlo B Gambacorti-PasseriniLuca Mologni
Published in: Leukemia (2024)
Keyphrases
  • chronic myeloid leukemia
  • tyrosine kinase
  • epidermal growth factor receptor
  • acute lymphoblastic leukemia
  • advanced non small cell lung cancer